title: A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design.
abstract: BACKGROUND
  Neoadjuvant radiochemotherapy (RCT) is now part of the armamentarium of cancer of the lower and middle rectum. It is recommended in current clinical practice prior to surgical excision if the lesion is classified T3/T4 or N+. Histological complete response, defined by the absence of persistent tumor cell invasion and lymph node (ypT0N0) after pathological examination of surgical specimen has been shown to be an independent prognostic factor of overall survival and disease-free survival. Surgical excision is usually performed between 6 and 8 weeks after completion of CRT and pathological complete response rate ranges around 12%. In retrospective studies, a lengthening of the interval after RCT beyond 10 weeks was found as an independent factor increasing the rate of pathological complete response (between 26% and 31%), with a longer disease-free survival and without increasing the operative morbidity. The aim of the present study is to evaluate in 264 patients the rate of pathological complete response rate of rectal cancer after RCT by lengthening the time between RCT and surgery.
  
  
  METHODS
  The current study is a multicenter randomized trial in two parallel groups comparing 7 and 11 weeks of delay between the end of RCT and cancer surgery of rectal tumors. At the end of the RCT, surgery is planified and randomization is performed after patient's written consent for participation. The histological complete response (ypT0N0) will be determined with analysis of the complete residual tumor and double reading by two pathologists blinded of the group of inclusion. Patients will be followed in clinics for 5 years after surgery. Participation in this trial does not change patient's management in terms of treatment, investigations or visits. Secondary endpoints will include overall and disease free survival, rate of sphincter conservation and quality of mesorectal excision. The number of patients needed is 264.
  
  
  BACKGROUND
  ClinicalTrial.gov: NCT01648894.
authors.affiliation: Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Digestive Surgery, Hôpital Saint-Antoine, 184, rue du Fbg Saint-Antoine, 75012 Paris, France. jeremie.lefevre@sat.aphp.fr.
authors.forename: Jérémie H
authors.initials: JH
authors.lastname: Lefevre
authors.forename: Alexandra
authors.initials: A
authors.lastname: Rousseau
authors.forename: Magali
authors.initials: M
authors.lastname: Svrcek
authors.forename: Yann
authors.initials: Y
authors.lastname: Parc
authors.forename: Tabassome
authors.initials: T
authors.lastname: Simon
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Tiret
mesh_terms: D059248:Chemoradiotherapy; D005500:Follow-Up Studies; D006801:Humans; D020360:Neoadjuvant Therapy; D012004:Rectal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D012074:Remission Induction; D012107:Research Design; D013997:Time Factors; D016896:Treatment Outcome
references.citation: Ann Surg Oncol. 2013 May;20(5):1551-9
references.pmid: 23188545
references.citation: Ann Surg Oncol. 2008 Oct;15(10):2661-7
references.pmid: 18389322
references.citation: J Gastrointest Surg. 2011 Mar;15(3):444-50
references.pmid: 21140237
references.citation: Ann Surg. 2009 Oct;250(4):582-9
references.pmid: 19710605
references.citation: J Am Coll Surg. 2002 Feb;194(2):131-5; discussion 135-6
references.pmid: 11848629
references.citation: Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8
references.pmid: 15383798
references.citation: Dis Colon Rectum. 2011 Oct;54(10):1251-9
references.pmid: 21904139
references.citation: Ann Surg. 2008 Aug;248(2):243-51
references.pmid: 18650634
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8688-96
references.pmid: 16246976
references.citation: Ann Surg. 2009 Aug;250(2):187-96
references.pmid: 19638912
references.citation: Br J Surg. 2005 Feb;92(2):225-9
references.pmid: 15609382
references.citation: Dis Colon Rectum. 2003 Mar;46(3):298-304
references.pmid: 12626903
references.citation: Dis Colon Rectum. 2003 Apr;46(4):448-53
references.pmid: 12682535
references.citation: Ann Surg Oncol. 2011 Jun;18(6):1590-8
references.pmid: 21207164
references.citation: Lancet. 1986 Jun 28;1(8496):1479-82
references.pmid: 2425199
references.citation: Ann Oncol. 2010 Mar;21(3):518-524
references.pmid: 19759186
references.citation: Ann Surg. 2006 Dec;244(6):1024-30
references.pmid: 17122629
references.citation: Recent Results Cancer Res. 1988;110:130-3
references.pmid: 3043588
references.citation: J Clin Oncol. 2005 Sep 1;23(25):6199-206
references.pmid: 16135487
references.citation: Lancet. 1993 Feb 20;341(8843):457-60
references.pmid: 8094488
references.citation: Dis Colon Rectum. 2012 Mar;55(3):e31; author reply e31-2
references.pmid: 22469807
references.citation: Gastroenterol Clin Biol. 2007 Jan;31 Spec No 1:1S34-51, 1S91-5
references.pmid: 17569476
references.citation: J Clin Oncol. 2005 Aug 20;23(24):5620-7
references.pmid: 16009958
references.citation: N Engl J Med. 2006 Sep 14;355(11):1114-23
references.pmid: 16971718
references.citation: Lancet. 1986 Nov 1;2(8514):996-9
references.pmid: 2430152
references.citation: Ann Surg. 2004 Aug;240(2):205-13
references.pmid: 15273542
references.citation: Ann Surg. 2010 Dec;252(6):998-1004
references.pmid: 21107110
references.citation: Dis Colon Rectum. 2001 Aug;44(8):1123-8
references.pmid: 11535851
references.citation: N Engl J Med. 1997 Apr 3;336(14):980-7
references.pmid: 9091798
references.citation: Lancet. 1996 Dec 14;348(9042):1605-10
references.pmid: 8961989
references.citation: Ann Surg. 2002 Jul;236(1):75-81
references.pmid: 12131088
references.citation: J Clin Oncol. 2006 Oct 1;24(28):4620-5
references.pmid: 17008704
references.citation: N Engl J Med. 2001 Aug 30;345(9):638-46
references.pmid: 11547717
references.citation: Br J Surg. 2002 Aug;89(8):1008-13
references.pmid: 12153626
references.citation: Int J Colorectal Dis. 1997;12(1):19-23
references.pmid: 9112145
references.citation: Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877-81
references.pmid: 15523225
references.citation: J Clin Oncol. 1999 Aug;17(8):2396
references.pmid: 10561302
references.citation: Gastroenterol Clin Biol. 2007 Jan;31 Spec No 1:1S23-33, 1S89-91
references.pmid: 17569475
references.citation: Ann Surg Oncol. 2006 Aug;13(8):1047-53
references.pmid: 16865595
references.citation: Cancer. 1990 Jul 1;66(1):49-55
references.pmid: 2191763
references.citation: Stat Med. 1991 Jun;10(6):925-35; discussion 936-7
references.pmid: 1876782
references.citation: J Clin Oncol. 2002 Feb 1;20(3):817-25
references.pmid: 11821466
references.citation: Dis Colon Rectum. 2004 Mar;47(3):279-86
references.pmid: 14991488